This inventor holds 2 USPTO granted patents. Top assignee: Novocure Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Ido Imanuel: Innovator in Tumor Treating Fields Technology
Introduction
Ido Imanuel is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of medical technology, particularly in the development of systems for delivering tumor treating fields. His innovative approaches have led to the filing of multiple patents, showcasing his expertise and commitment to advancing healthcare solutions.
Latest Patents
Ido Imanuel holds 2 patents that focus on systems and methods for determining transducer locations for delivering tumor treating fields. His first patent describes a computer-implemented method for selecting transducer locations based on a three-dimensional model of the subject. This method involves computing an initial vector for each transducer location and selecting optimal locations based on electrical potentials. The second patent outlines a similar approach but utilizes a discretized model of the subject, enhancing the accuracy of the transducer location selection process.
Career Highlights
Ido Imanuel is currently employed at Novocure GmbH, a company dedicated to developing innovative cancer treatments. His work at Novocure has positioned him as a key player in the advancement of tumor treating fields technology. His contributions have the potential to improve treatment outcomes for patients suffering from various types of cancer.
Collaborations
Ido collaborates with talented professionals in his field, including Michal Holtzman Gazit and Reuven Ruby Shamir. These collaborations enhance the innovative processes at Novocure and contribute to the development of cutting-edge medical technologies.
Conclusion
Ido Imanuel's work in the field of tumor treating fields technology exemplifies the impact of innovation in healthcare. His patents and career at Novocure GmbH highlight his dedication to improving cancer treatment methodologies. Through his efforts, Ido continues to pave the way for advancements that can significantly benefit patients worldwide.